Panuveitis Market Report 2026

Panuveitis Market Overview

• Panuveitis market size has reached to $4.46 billion in 2025 • Expected to grow to $7.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Autoimmune Disorder Prevalence Fueling The Market Growth • Market Trend: Advancements In Slow-Release Intravitreal Injection Therapies For Retinal Diseases • North America was the largest region in 2025.

What Is Covered Under Panuveitis Market?

Panuveitis is a condition characterized by inflammation affecting all three layers of the uvea including the iris, ciliary body, and choroid inside the eye. If not treated, it can cause pain, and blurred vision, and potentially lead to vision loss. The goal of treatment is to control inflammation, relieve symptoms, and prevent further damage to the eye that could impair vision. Timely intervention is essential to protect eye health and maintain vision. The main types of panuveitis are infectious panuveitis and non-infectious panuveitis. Infectious panuveitis is an inflammation of the uveal tract caused by infectious agents requiring timely diagnosis and treatment to prevent serious eye complications and vision loss. It is treated with various treatments such as pharmacological, surgical, and phototherapy and administered through several routes of administration, including oral, intravitreal, and topical. It is distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Panuveitis Market Growth Forecast?

The panuveitis market size is expected to see strong growth in the next few years. It will grow to $7.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to advancements in biologics and immunomodulatory drugs, increasing prevalence of autoimmune and infectious eye disorders, growth in teleophthalmology services, rising investments in ai-assisted diagnostics, expansion of hospital and retail pharmacy distribution channels. Major trends in the forecast period include increasing adoption of targeted biologic therapies, rising use of teleophthalmology and remote monitoring, integration of ai-based diagnostic tools for eye inflammation, growth in personalized treatment approaches, expansion of specialized ophthalmology centers.

Global Panuveitis Market Segmentation

1) By Type: Infectious Panuveitis, Non-Infectious Panuveitis 2) By Treatment: Pharmacological, Surgical, Phototherapy 3) By Route Of Administration: Oral, Intravitreal, Topical 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Infectious Panuveitis: Bacterial Panuveitis, Viral Panuveitis, Fungal Panuveitis, Parasitic Panuveitis 2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis, Idiopathic Panuveitis, Drug-Induced Panuveitis

What Is The Driver Of The Panuveitis Market?

The rising prevalence of autoimmune disorders is expected to propel the growth of the panuveitis market going forward. Autoimmune diseases arise when the immune system incorrectly targets and damages the body's own healthy cells and tissues. The rising prevalence of autoimmune diseases is due to factors such as a combination of genetic predispositions, environmental factors such as pollution and dietary changes, and increased exposure to certain infections and stressors that may trigger immune system dysregulation. Autoimmune disorders contribute to advancements in panuveitis treatment by driving research into immune system modulation, as many panuveitis cases are related to autoimmune activity. For instance, in May 2023, according to the University of Oxford, a UK-based research university, autoimmune disorders affect 10% of the world's population, with 13% of women and 7% of males affected. Therefore, the rising prevalence of autoimmune disorders is driving the growth of the panuveitis industry.

Key Players In The Global Panuveitis Market

Major companies operating in the panuveitis market are Pfizer Inc., AbbVie, Amgen, Mallinckrodt plc, EyePoint Pharmaceuticals Inc., Clearside Biomedical Inc., pSivida Corp., Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Novartis AG, F Hoffmann‑La Roche AG, Regeneron Pharmaceuticals Inc, Sanofi S A, Bausch Health Companies Inc, Johnson & Johnson, UCB SA, Aldeyra Therapeutics Inc, Kiora Pharmaceuticals Inc, Lux Biosciences Inc, Aciont Inc, Sirion Therapeutics Inc, EyeGate Pharmaceuticals Inc, Oculis Pharma AG, Alcon Inc, Sun Pharmaceutical Industries Ltd, Aerie Pharmaceuticals Inc.

Global Panuveitis Market Trends and Insights

Major companies operating in the panuveitis market are focusing on developing innovative products, such as oral TYK2/JAK-1 inhibitors, to gain a competitive advantage. These are small-molecule immunomodulators that block inflammatory signaling pathways by inhibiting both TYK2 and JAK-1 kinases, thereby reducing cytokine-driven inflammation in the eye. For instance, in April 2024, Roivant Sciences, a US-based biopharma company, announced positive mid-stage clinical data for brepocitinib from its NEPTUNE study in non-infectious uveitis (including panuveitis). The drug showed efficacy in reducing inflammation and macular edema and was well tolerated, with no new safety signals. In parallel, Alumis, a US biotherapeutic company, in June 2023 initiated dosing in its Phase 2 proof-of-concept ESK-001 trial for non-infectious uveitis, including panuveitis; this molecule is highly selective, orally bioavailable, and designed to minimize off-target effects via allosteric TYK2 inhibition.

What Are Latest Mergers And Acquisitions In The Panuveitis Market?

In July 2023, Harrow Health Inc., a US-based pharmaceutical company, acquired Santen Pharmaceutical Co., Ltd. for an undisclosed amount. With this acquisition, Harrow aims to expand its portfolio by incorporating Santen's expertise in providing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd. is a Japan-based company that offers treatments for panuveitis.

Regional Outlook

North America was the largest region in the panuveitis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Panuveitis Market?

The panuveitis market consists of revenues earned by entities providing services such as pharmaceutical treatment, surgical interventions, diagnostic services, and supportive care. The market value includes the value of related goods sold by the service providers or included within the service offering. The panuveitis market also includes sales of diagnostic tools, pharmaceuticals, biologic agents, immunosuppressive drugs, and supportive care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Panuveitis Market Report 2026?

The panuveitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the panuveitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.